{"id":1043,"date":"2026-03-17T10:46:22","date_gmt":"2026-03-17T14:46:22","guid":{"rendered":"https:\/\/www.calljed.com\/blog\/?p=1043"},"modified":"2026-03-17T10:46:22","modified_gmt":"2026-03-17T14:46:22","slug":"dupixent-lawsuits-claims-risks-and-compensation","status":"publish","type":"post","link":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/","title":{"rendered":"Dupixent Lawsuits: Claims, Risks, and Compensation"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1044\" src=\"https:\/\/www.calljed.com\/blog\/wp-content\/uploads\/2026\/03\/3-17-26-Dupixent-Lawsuit-300x200.jpg\" alt=\"3-17-26-Dupixent-Lawsuit-300x200\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.calljed.com\/blog\/wp-content\/uploads\/2026\/03\/3-17-26-Dupixent-Lawsuit-300x200.jpg 300w, https:\/\/www.calljed.com\/blog\/wp-content\/uploads\/2026\/03\/3-17-26-Dupixent-Lawsuit-768x512.jpg 768w, https:\/\/www.calljed.com\/blog\/wp-content\/uploads\/2026\/03\/3-17-26-Dupixent-Lawsuit-180x120.jpg 180w, https:\/\/www.calljed.com\/blog\/wp-content\/uploads\/2026\/03\/3-17-26-Dupixent-Lawsuit.jpg 1000w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><br \/>\nDupixent is one of the most-frequently prescribed drugs for eczema and asthma, but scientists believe that taking it could put patients at risk for cutaneous T-cell lymphoma, a rare type of cancer that can attack skin tissue and blood cells.<\/p>\n<p>If you or a loved one has been diagnosed with cutaneous T-cell lymphoma after taking Dupixent, you could be entitled to significant compensation.<\/p>\n<p>Here is what you need to know about:<\/p>\n<div class=\"read_more_link\"><a href=\"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/\"  title=\"Continue Reading Dupixent Lawsuits: Claims, Risks, and Compensation\" class=\"more-link\">Continue reading<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dupixent is one of the most-frequently prescribed drugs for eczema and asthma, but scientists believe that taking it could put patients at risk for cutaneous T-cell lymphoma, a rare type of cancer that can attack skin tissue and blood cells. If you or a loved one has been diagnosed with cutaneous T-cell lymphoma after taking [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[37,44,9,10,38,63],"class_list":["post-1043","post","type-post","status-publish","format-standard","hentry","category-product-liability","tag-attorney","tag-compensation","tag-injury","tag-lawyer","tag-personal-injury","tag-product-liability"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dupixent Lawsuits: Claims, Risks, and Compensation &#8212; Buffalo Personal Injury Lawyer News &#8212; March 17, 2026<\/title>\n<meta name=\"description\" content=\"Dupixent is one of the most-frequently prescribed drugs for eczema and asthma, but scientists believe that taking it could put patients at risk for &#8212; March 17, 2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Dupixent Lawsuits: Claims, Risks, and Compensation &#8212; Buffalo Personal Injury Lawyer News &#8212; March 17, 2026\" \/>\n<meta name=\"twitter:description\" content=\"Dupixent is one of the most-frequently prescribed drugs for eczema and asthma, but scientists believe that taking it could put patients at risk for &#8212; March 17, 2026\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.calljed.com\/blog\/wp-content\/uploads\/2026\/03\/3-17-26-Dupixent-Lawsuit.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dietrich Law Firm P.C.\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dupixent Lawsuits: Claims, Risks, and Compensation &#8212; Buffalo Personal Injury Lawyer News &#8212; March 17, 2026","description":"Dupixent is one of the most-frequently prescribed drugs for eczema and asthma, but scientists believe that taking it could put patients at risk for &#8212; March 17, 2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/","twitter_card":"summary_large_image","twitter_title":"Dupixent Lawsuits: Claims, Risks, and Compensation &#8212; Buffalo Personal Injury Lawyer News &#8212; March 17, 2026","twitter_description":"Dupixent is one of the most-frequently prescribed drugs for eczema and asthma, but scientists believe that taking it could put patients at risk for &#8212; March 17, 2026","twitter_image":"https:\/\/www.calljed.com\/blog\/wp-content\/uploads\/2026\/03\/3-17-26-Dupixent-Lawsuit.jpg","twitter_misc":{"Written by":"Dietrich Law Firm P.C.","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/#article","isPartOf":{"@id":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/"},"author":{"name":"Dietrich Law Firm P.C.","@id":"https:\/\/www.calljed.com\/blog\/#\/schema\/person\/2ee8134afc102b1d1ae2b35358f668de"},"headline":"Dupixent Lawsuits: Claims, Risks, and Compensation","datePublished":"2026-03-17T14:46:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/"},"wordCount":578,"image":{"@id":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.calljed.com\/blog\/wp-content\/uploads\/2026\/03\/3-17-26-Dupixent-Lawsuit-300x200.jpg","keywords":["attorney","compensation","injury","lawyer","personal injury","product liability"],"articleSection":["Product Liability"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/","url":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/","name":"Dupixent Lawsuits: Claims, Risks, and Compensation &#8212; Buffalo Personal Injury Lawyer News &#8212; March 17, 2026","isPartOf":{"@id":"https:\/\/www.calljed.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/#primaryimage"},"image":{"@id":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.calljed.com\/blog\/wp-content\/uploads\/2026\/03\/3-17-26-Dupixent-Lawsuit-300x200.jpg","datePublished":"2026-03-17T14:46:22+00:00","author":{"@id":"https:\/\/www.calljed.com\/blog\/#\/schema\/person\/2ee8134afc102b1d1ae2b35358f668de"},"description":"Dupixent is one of the most-frequently prescribed drugs for eczema and asthma, but scientists believe that taking it could put patients at risk for &#8212; March 17, 2026","breadcrumb":{"@id":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/#primaryimage","url":"https:\/\/www.calljed.com\/blog\/wp-content\/uploads\/2026\/03\/3-17-26-Dupixent-Lawsuit.jpg","contentUrl":"https:\/\/www.calljed.com\/blog\/wp-content\/uploads\/2026\/03\/3-17-26-Dupixent-Lawsuit.jpg","width":1000,"height":667},{"@type":"BreadcrumbList","@id":"https:\/\/www.calljed.com\/blog\/dupixent-lawsuits-claims-risks-and-compensation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.calljed.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Dupixent Lawsuits: Claims, Risks, and Compensation"}]},{"@type":"WebSite","@id":"https:\/\/www.calljed.com\/blog\/#website","url":"https:\/\/www.calljed.com\/blog\/","name":"Buffalo Personal Injury Lawyer News","description":"Published by Buffalo, New York Personal Injury Attorneys \u2014 Dietrich Law Firm P.C.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.calljed.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.calljed.com\/blog\/#\/schema\/person\/2ee8134afc102b1d1ae2b35358f668de","name":"Dietrich Law Firm P.C.","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/156c75494907e6612cf0ecfa1f0139c645885b2b2c122df966b5127bf0dd6c53?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/156c75494907e6612cf0ecfa1f0139c645885b2b2c122df966b5127bf0dd6c53?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/156c75494907e6612cf0ecfa1f0139c645885b2b2c122df966b5127bf0dd6c53?s=96&d=mm&r=g","caption":"Dietrich Law Firm P.C."},"sameAs":["https:\/\/www.calljed.com\/our-firm.html"]}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.calljed.com\/blog\/wp-json\/wp\/v2\/posts\/1043","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.calljed.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.calljed.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.calljed.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.calljed.com\/blog\/wp-json\/wp\/v2\/comments?post=1043"}],"version-history":[{"count":1,"href":"https:\/\/www.calljed.com\/blog\/wp-json\/wp\/v2\/posts\/1043\/revisions"}],"predecessor-version":[{"id":1045,"href":"https:\/\/www.calljed.com\/blog\/wp-json\/wp\/v2\/posts\/1043\/revisions\/1045"}],"wp:attachment":[{"href":"https:\/\/www.calljed.com\/blog\/wp-json\/wp\/v2\/media?parent=1043"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.calljed.com\/blog\/wp-json\/wp\/v2\/categories?post=1043"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.calljed.com\/blog\/wp-json\/wp\/v2\/tags?post=1043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}